Showing results (2141-2150 of 2,332) with videos related to

Sort By:
Pageof 234
The American Journal of Tropical Medicine and Hygiene|October 29, 2009
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteersPeter F Wright, Anna P Durbin, Stephen S Whitehead, et al.
JAMA Internal Medicine|July 21, 2025
Frequent Missed Opportunities for Earlier Diagnosis of Advanced-Stage Colorectal or Lung CancerAndrew J Zimolzak, Paarth Kapadia, Divvy K Upadhyay, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 18, 2024
Assessing meaningful change in the Asthma Impairment and Risk QuestionnaireWilliam McCann, Kevin R Murphy, Robert S Zeiger, et al.
The Journal of Infectious Diseases|December 11, 1976
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adultsD D Richman, B R Murphy, R M Chanock, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2022
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma ExacerbationsDavid A Beuther, Kevin R Murphy, Robert S Zeiger, et al.
Evolutionary Applications|September 10, 2020
Comparison of genomic diversity and structure of sable antelope (Hippotragus niger) in zoos, conservation centers, and private ranches in North AmericaRebecca M Gooley, Gaik Tamazian, Susette Castañeda-Rico, et al.
JAMA|December 28, 1999
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trialJ Kahn, S Lagakos, M Wulfsohn, et al.
Vaccine|May 26, 2009
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adultsKawsar R Talaat, Ruth A Karron, Karen A Callahan, et al.
Diabetes Care|November 30, 2012
Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trialDaniela Elleri, Janet M Allen, Kavita Kumareswaran, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
Pageof 234